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Objective: To study the effects of PDGF-Rb antagonists imatinib on endometrial injury
repairing in the mouse model.
Methods: The cultured MSCs cells from male mice were marked with BrdU in vitro, and
then transplanted to the female mice which suffered from radiation injury through tail
vein, PDGF-Rb antagonists imatinib was injected through abdominal cavity. Four groups
were arranged, which were radiation transplantation group, normal control group, ima-
tinib intervention group and radiation control group. BrdU incorporation, SRY expression
and MVD status were detected in uterus of mice.
Results: SRY gene was negative expressed in normal control group and radiation control
group. SRY gene presented positive in radiation transplantation group and imatinib
intervention group; BrdU incorporation showed negative in radiation control group and
normal control group which died in the early stage in mice; the incorporation of BrdU
was higher in radiation transplantation group compared with imatinib intervention group;
CD34 was positive on the uterus of all the four groups, which showed highest in radiation
control group and lowest in radiation control group; The MVD in imatinib intervention
group was lower than radiation control group; the difference of MVD was signiﬁcantly
compared with normal control group (P < 0.05).
Conclusions: PDGF-Rb antagonists imatinib could inhibit the repairing function of
MSCs in the endometrial lesions in mice.1. Introduction
In recent years, with the development of assisted reproduc-
tive technology such as embryo freezing, patients have got
multiple opportunities for embryo transfer, which makes the role
of the receptivity of endometrium more important in pregnancy.
Although endometrium has a strong ability of proliferation, it is
easily injured by intrauterine operation and tuberculosis infec-
tion, thus leading to the thinning of endometrium and reducing
of ability to conceive. Currently, due to reasons such as ethics,
surrogacy is banned in many countries [1], and uterus transplant
exists risks such as immunological rejection, therefore moreattention is drawn to researches of endometrial repair after
injury. In previous studies, scientists found the phenomena
such as exogenous mesenchymal stem cell and embedded
endometrial cell in the female patients with bone marrow
transplantation, among which mesenchymal stem cell can
probably develop to endometrial stem cells and plays an
important role in periodic proliferation of endometrium. It is
believed that CD146 and platelet-derived growth factor-
receptor beta (PDGF-Rb) are expressed in endometrial stem
cells and is the marker of endometrial stem cells [2]. PDGF is
important promote mitosis and chemotactic agent in the body,
which can promote proliferation, transfer and chemotaxis of a
variety of histocytes and is helpful to the tissue repair of
different kinds of injuries [3]. In previous studies, we found
that PDGF-Rb has a certain correlation with the thickness of
endometrium. In order to further explore the effect of PDGF-Rb
on ectomesenchymal stem cells in the process of endometrial
injury repairing, bone marrow mesenchymal stem cell was car-
ried out in mice with endometrial injury induced by radiation.
Through intraperitoneal injection of PDGF-Rb receptorpen access article under the CC BY-NC-ND
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mesenchymal stem cell in mice in the process of endometrial
injury repairing.
2. Materials and methods
2.1. Reagents
PDGF-Rb antagonist imatinib (Glivec, 100 mg/tablet) was
purchased from Beijing Novartis Pharma Ltd. BrdU powder and
the antibody were provided by Wuhan Boster Biological Engi-
neering Co., Ltd. Rabbit anti-mouse polyclonal CD34 antibody
and rabbit anti-mouse polyclonal CD29 antibody were pur-
chased from Beijing Zhongshan Golden Bridge Biotechnology
Co., Ltd.
2.2. Experimental animals
Adult KM mice of clean degree, aging 6–7 weeks, weighting
25–30 g were provided by Laboratory AnimaI Centre of Luye
Pharma Group Ltd. [license no. SCXK (Lu) 20090013]. The
genetic relationship of male and female mice was marked, and
brothers and sisters were selected for bone marrow
transplantation.
2.3. Primary culture and identiﬁcation of mesenchymal
stem cell by whole bone marrow adherent method and
BrdU marking method
Six week-old mice were selected and killed by dislocation.
The thighbone and tibia bone marrows were collected for cell
culture and were transplanted with puriﬁcation of mesenchymal
stem cells [4,5]. In the process of part of the puriﬁcation of MSCs
cell passages, complete medium containing 30 mg/mL BrdU was
added and cultured for 48 h. BrdU antibody was used to detect the
BrdU marking positive rate of MSCs [6]. Marking positive
rate = BrdU positive cell/total MSCs × 100%. According to the
biological characteristics of MSCs, CD34 and CD29 antibodies
were used for immunohistochemical analysis to decide whether
it was mesenchymal stem cell [7]. The puriﬁed MSCs marked
with BrdU was brushed by cytobrush, repeatedly beat into cell
suspension and centrifuged for further use.
2.4. Transplantation of mesenchymal stem cell
The lethal dose of receptors in mice was calculated with body
surface area and volume of the mice. Rotary cobalt-60 therapy
unit was used for the irradiation of gamma rays in receptor body
of female mice with the dosage rate of 1.0 Gy/min and the total
dose of 8 Gy [8]. Within 2 h after radiotherapy, mesenchymal
stem cell was transplanted in female mice (the brood male and
female mice were strictly selected for the transplantation ofTable 1
Groups of female mice and intervention measures.
Groups Radiotherapy dose
Radiation transplantation group 8 Gy
Imatinib intervention group 8 Gy
Radiation control group 8 Gy
Normal control group 0mesenchymal stem cell to avoid immunological rejection), and
serum-free DMEM medium was used to adjust the cell density
to 5 × 107 cells/mL and 0.1 mL cell sap was injected to receptor
mice through caudal vein [4,5]. PDGF-Rb receptor antagonist
imatinib was diluted to 1% aqueous solution with normal saline
and was intraperitoneally injected with 0.2 mL according to the
mice weight (75 mg/kg) [9]. A total of 32 female mice were used
in this study with 8 mice in each group. The mice were divided
into groups for intervention according to Table 1.
2.5. Observation of post-transplant, trace of BrdU and
trace detection of Y-chromosome
Female mice of each group were fed in sterile laminar ﬂow
cabinet and given 2 × 105 U/L sterile water. The survival time of
mice was recorded. After 30 d, mice were killed by dislocation.
One side of the uterus was ﬁxed with 4% paraformaldehyde and
performed HE staining and BrdU immunohistochemistry to
observe the endometrial injury repairing. The other side of the
ovary and uterus were placed at −70 C to detect SRY gene by
PCR. qRT-PCR was used to detect the gene expression of the
sex determining region Y in the uterus of mice. Primer se-
quences are as follows: F: 50-GCTGGGATGCAGGTG-
GAAAA-30, R: 50-CCCTCCGATGAGGCTGATATT-30,
length: 150 bp.
2.6. Detection of microvessel density
Microvessel density of uterus tissue in each group of mice
were detected with the primary antibody CD34 according to the
method of Weidner et al [2].
2.7. Statistical analysis
BrdU cell nucleus with claybank particle deposition was
positive cell. The section was observed under 200× light mi-
croscope. IMAGE-PROPLUS was used for the analysis of rate
of positive cells. Each group selected 30 sections and two
different horizons were selected for quantitative analysis in each
section. Furthermore, the staining intensity of positive cell was
transferred to quantitative indicator to calculate its average op-
tical density. Results were expressed as mean ± sd. SPSS17.0
statistical software was used for the variance analysis and t test.
3. Results
3.1. Culture and identiﬁcation of MSCs
The culture medium was changed after 48 h of the culture of
primary mesenchymal stem cell, and many adherent cells were
observed under the microscope. After 3–4 day of culture, more
cells were polygonal or fusiform and grew to clone shape. AfterTail vain injection Intraperitoneal injection
0.1 mL MSCs cell suspension 0.2 mL normal saline
0.1 mL MSCs cell suspension 0.2 mL 1% imatinib
0.1 mL DMEM 0.2 mL normal saline
0.1 mL DMEM 0.2 mL normal saline
Figure 3. MSCs marked with BrdU (200×).
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passaged (Figure 1). Immunohistochemistry technology was
used to authenticate CD29 (+) and CD34 (−) cells. Results
showed that the obtained cells had character of mesenchymal
stem cell (Figure 2). Meanwhile, BrdU marking positive rate
was as high as 80% (Figure 3).
3.2. Survival situation of mice in different groups
After the irradiation of g ray, mental atrophy, loss of weight
and hair loose began to be appeared in mice. In radiation control
group, mice successively died 4 days after radiotherapy; 14 days
after radiotherapy, dead mice were eight. In radiation trans-
plantation group, a total of 2 mice died after 14 days of trans-
plantation, and before death, mice arched backs and refused food
and water. After 14 days of transplantation, the activity and
feeding of the survival mice was increased compared with that
before 2 weeks. The body weight was also gradually increased.
The survival time of two mice was about 20 days, while that of
four mice could reach 30 days. No death was found in the mice
of normal control group. The mice dying in radiation trans-
plantation group were dissected. Results showed that the mice
died in the early stage of radiotherapy (within 14 day of radio-
therapy) became to have the symptoms of intestinal contents
decrease and intestinal canal ﬂatulence. Mice died at other time
did not ﬁnd the obvious lesions of celiac intestinal canal, but the
uterus was small and ovary was pale and smooth. Three mice
were dead in imatinib intervention group within 14 days, among
which 2 were dead in 22nd and 25th day, respectively, and 3
were survived to 30 days.
3.3. Detection of pathology of the uterus
HE staining results showed that uterus in radiation control
group was smaller than that in normal control group. TheFigure 1. Primary culture of MSCs (200×) (A) and MSCs of the third
generation (200×) (B).
Figure 2. MSCs marked with CD29 (200×) (A) and with CD34
(200×) (B).endometrial layer became thinner and the incidence rate of
endometrial layer gland sag was decreased. The endometrium of
mice in radiation transplantation group and imatinib intervention
group was scattered in endometrial glands (Figure 4).
3.4. BrdU quantiﬁcation of the uterus of mice
In the early death mice of normal control, radiation control
and radiation transplantation groups, BrdUs of uteruses were
negative. In the uterus of survival mice in radiation trans-
plantation and imatinib intervention groups, BrdU mainly
expressed in capillary endothelial cell and the small amount of
stromal cells (Figure 4), and BrdU expression in radiation
transplantation group was stronger than that in imatinib inter-
vention group (P < 0.05).
3.5. Trace detection of Y-chromosome in the uterus
tissue of mice
In female mice (negative control), SRY expression was
negative, while SRY expression of male mice (positive control)
was positive. qPCR results showed that SRY gene expression
was not detected in both radiation control and normal control
groups, but the SRY gene expressions were positive in radiation
transplantation and imatinib intervention groups (Figure 5).
3.6. Microvessel density of uterus of mice
CD34 positive cells could be found in the uterus of mice in
different groups of which the normal control was the highest and
radiation control was the lowest. MVD in imatinib intervention
group was lower than that in radiation transplantation group.
Compared with normal control group, the changes of MVD in
other three groups were signiﬁcantly different (P < 0.05)
(Table 2).Figure 4. BrdU mark of uterus in radiation transplantation group (100×)
(A) and in imatinib intervention group (100×) (B).
Figure 5. Expression of SRY gene by general PCR detection (A) and qRT-PCR detection (B).
1. adult male mice (positive control); 2. normal control group; 3, 4: radiation transplantation group; 5, 6: imatinib intervention group; M: PCR marker.
L1: adult male mice (positive control); L2: normal control group; L3, L4: radiation transplantation group; L5, L6: imatinib intervention group.
Table 2
Comparision of BrdU, SRY and MVD in uterus tissue of mice in different
groups.
Groups Brdu SRY MVD
Normal control – Negative 8.38 ± 2.34
Radiation control – Negative 2.06 ± 1.12#
Radiation transplantation
group
0.214 ± 0.072 Positive 3.94 ± 1.49#
Imatinib intervention
group
0.134 ± 0.053* Positive 2.71 ± 0.92#
*Compared with radiation transplantation group, the difference was
signiﬁcant (P < 0.05). #Compared with normal control group, the dif-
ference was signiﬁcant (P < 0.05).
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Bone marrow mesenchymal stem cells have strong prolif-
eration ability and have multipotential differentiation [10].
Domestic and overseas scholars have studied the
transplantation of bone marrow mesenchymal stem cells and
proved that mesenchymal stem cell can migrate to a variety
of tissues and organs and may provide cell origination for
tissue injury repairing [11]. Taylor et al detected the HLA
antigen in the endometrium of 4 female patients with bone
marrow transplantation and found gene of the donor, which
indicated that bone marrow stem cell of donor was helpful to
the regeneration of endometrial in recipient [12]. We choose
radiotherapy to injury the endometrium because radiotherapy
injury has no drug residues compared with chemical injury,
and has no inhibition to cells after transplantation.
Radiological dose reached sublethal dose, and no mouse was
dead in radiation control group within 14 days. We cultured
the bone marrow-derived MSC of male mice in vitro and
transplanted to female mice after radiotherapy to establish the
model of bone marrow-derived mesenchymal stem cells in
mice with endometrial injury and explore the effect of PDGF-
Rb receptor antagonist imatinib on endometrial injury
repairing.
PDGF-Rb and its receptor pathway is one of the important
pathways of speciﬁc regulating proliferation and migration of
capillary pericytes. The newborn capillaries involve in the tis-
sue repair process through angiogenesis. Imatinib is a kind of
PDGF-Rb receptor antagonist that can effectively inhibit
PDGF-Rb and receptor pathway. In the in vitro study of Grifﬁth
et al, it showed that imatinib can reduce transmembrane
transport and proliferation of matrix cell in extracellular matrix
culture system via inhibiting the effect of endometrialproliferation and can be used in the treatment of endometriosis
[13]. Therefore, we believed that imatinib can interdict the role
of PDGF-Rb pathway and inhibit the generation of microvas-
cular, thus inhibit tissue repair process [10]. The results in the
present study showed that in radiation control group, 87.5%
mice were dead within the 14 days of radiotherapy, with the
less endometrial glands which showed that the purpose of
endometrium to injury was achieved. No mouse was dead in
normal control group and the endometrial glands and
thickness were normal. Gene expressions of BrdU and SRY in
radiation transplantation group and imatinib intervention
group were positive, while BrdU in radiation control group
and normal control group were positive, and SRY gene
expression was highly expressed in the two groups, which
indicated that in vitro MSCs could migrate to uterus and
mainly locate in vascular endothelial cell of uterus and a
small amount of matrix cells. BrdU and microvessel density
in imatinib intervention group were lower than that in
radiation transplantation group, which indicated that PDGF-
Rb antagonists imatinib could inhibit the repair effect of
MSCs on endometrial injury in mice. The results in the present
study were consistent with the research of Grifﬁth et al [13].
In conclusion, endometrial receptivity is one of the important
factors of embryo transfer. More and more researchers pay
attention to the form and function of endometrium before
transplantation. Studying the mechanism of endometrial injury
repairing is beneﬁcial to promote the growth of endometrium
and provides a favorable environment for embryo growth.
Through animal model, we verify that blocking PDGF-Rb
pathway will inhibit the regeneration of endometrium, which
provides us a theoretical basis in the clinical work.
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